AXSM News and Press, Axsome Therapeutics Inc. From 11/04/22

The end of the year is right around the corner. But this time of year actually is a beginning for certain healthcare stocks. That's because important share-performance catalysts and/or revenue opportunities lie just ahead. And that's why these players make great buys in November. CRIS...

Shares of Axsome Therapeutics (NASDAQ: AXSM) were soaring 12.7% higher as of 11:19 a.m. ET on Thursday. The company didn't report any new developments, so what's behind the nice gain? There are two potential catalysts at the top of the list. Perhaps the most likely explanation f...

Summary Shares of Axsome Therapeutics have posted a 30% gain so far in 2022. There's a sizeable niche and unmet need in the MDD market that Auvelity could address (novel MOA for patients who don't respond to first-line treatment). High value indications such as Alzheimer's dis...

Summary The macroeconomic factors create a highly favorable mergers and acquisition environment. Several interesting deals are being executed this month. As it's a strong buyers' market, you're likely to see more buyouts going toward year-end and next year. Axsome is an ideal ...

There are pros and cons to investing in biotech stocks. One of the advantages is that shares of drugmakers can explode in a short period, especially following regulatory or clinical wins. On the other hand, the industry tends to be volatile, which may not suit some people's investment style...

NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executiv...

If you're looking to buy stocks, you don't need to have tens of thousands of dollars available to invest. Nowadays, with brokerages offering low or no-commission trading, even putting $500 toward a stock can be a great way to start building up your portfolio. And over time, you can add to y...

Axsome to host conference call and webcast on Monday, November 7, 2022 at 8:00 AM Eastern Time NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central ne...

AUVELITY is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week 1-4 Auvelity On My Side offers comprehensive patient support services including access...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock / Lane V. Erickson Social Security benefits are increasing for 2023 as the Social Security Administration announces an update to the Cost-of-Living Adjustment (COLA) . The COLA 2023 update will...